无针给药装置市场规模、份额及成长分析（按类型、应用和地区）- 产业预测 2025-2032

2023 年无针药物输送设备市场规模价值 141 亿美元，预计将从 2024 年的 150.7 亿美元增长到 2032 年的 257.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.9%。

无针药物输送设备的全球市场将透过提供传统针头药物输送的替代方案来彻底改变医疗保健产业。由于对无痛、以患者为中心的解决方案的需求不断增加，特别是针对自体免疫疾病和糖尿病等慢性病，该市场正在经历显着增长。经皮吸收贴片和喷射注射器等创新技术透过提供精确度和易用性，正在增加市场吸引力。目前它们主要用于医疗机构，但在居家照护环境中也迅速流行起来。吸入系统等最尖端科技的普及凸显了该行业对患者舒适度的关注。然而，高昂的开发成本和监管障碍等挑战可能会限製成长。总体而言，医疗保健的不断发展表明无针药物输送解决方案前景光明。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析
• 专利分析

无针给药装置市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 吸入器技术
• 经皮吸收贴片技术
• 全新无针技术

无针药物输送设备市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 疫苗递送
• 疼痛管理
• 糖尿病胰岛素
• 小儿注射
• 其他的

无针药物输送设备市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• PenJet（USA）
• Zealand Pharma（Denmark）
• UCB SA（Belgium）
• PharmaJet（USA）
• 3M（USA）
• Verdict Media Limited（UK）
• INJEX Pharma AG（Germany）
• Antares Pharma（USA）
• Endo Pharmaceuticals Inc.（USA）
• Bioject Medical Technologies, Inc.（USA）
• Crossject SA（France）
• MannKind Corporation（USA）
• Mika Medical Co.（South Korea）
• Halozyme, Inc.（USA）
• Akra Dermojet（Turkey）
• Zydus Group（India）
• Ferring BV（Switzerland）
• Gerresheimer AG（Germany）
• AptarGroup, Inc.（USA）
• MIIST Therapeutics（USA）

结论和建议

Needle-free Drug Delivery Devices Market size was valued at USD 14.1 billion in 2023 and is poised to grow from USD 15.07 billion in 2024 to USD 25.71 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global needle-free drug delivery devices market is poised to revolutionize the healthcare industry by offering alternatives to traditional needle-based drug administration. This market has witnessed significant growth, driven by the increasing demand for pain-free, patient-centric solutions, particularly for chronic conditions like autoimmune disorders and diabetes. Innovations like transdermal patches and jet injectors are enhancing market appeal by providing precision and ease of use. While healthcare facilities currently dominate usage, homecare settings are rapidly gaining popularity. The surge of cutting-edge technologies, such as inhalable systems, underscores the industry's focus on patient comfort. However, challenges like high development costs and regulatory hurdles could limit growth. Overall, the ongoing evolution in healthcare signals a promising future for needle-free drug delivery solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Needle-Free Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Needle-Free Drug Delivery Devices Market Segments Analysis

Global Needle-free Drug Delivery Devices Market is segmented by Type, Application and region. Based on Type, the market is segmented into Inhaler technology, Transdermal patch technology and Novel needle-free technologies. Based on Application, the market is segmented into Vaccine delivery, Pain management, Insulin delivery for diabetes, Pediatric injections and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Needle-Free Drug Delivery Devices Market

The Needle-Free Drug Delivery Devices market is thriving due to the advent of innovative devices that offer enhanced efficiency and precision. Continuous advancements in needle-free technology have paved the way for the emergence of sophisticated solutions such as transdermal patches, micro-needles, and jet injectors. These cutting-edge devices cater to a wide range of medical applications, capitalizing on the growing trend towards more effective and less invasive drug administration methods. As technology evolves, these delivery systems are not only becoming increasingly accurate but also adaptable to diverse therapeutic needs, positioning the market for substantial growth and transformation.

Restraints in the Needle-Free Drug Delivery Devices Market

The needle-free drug delivery devices market faces significant challenges due to stringent regulatory oversight within the medical device industry. The approval process for these innovative products can be lengthy and complex, creating obstacles for manufacturers. While these regulations are essential for ensuring patient safety and the effectiveness of injections, they also present hurdles that can lead to increased development costs and delays in production and distribution. As companies navigate the intricate landscape of regulatory compliance, the associated timeframes and financial implications can hinder the advancement and commercialization of needle-free drug delivery technologies.

Market Trends of the Needle-Free Drug Delivery Devices Market

The Needle-Free Drug Delivery Devices market is experiencing a dynamic shift as expanding applications in healthcare broaden its scope beyond traditional uses such as insulin and vaccines. The surge in interest in these devices over the past few years can be attributed to technological advancements that enable their application in specialized therapeutics and biologics, enhancing their versatility and appeal. As the demand for precise and controlled drug administration continues to rise alongside a move towards patient-centric care, the market is poised for further innovations and a diversification of uses, driving growth and evolution in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis
• Patent Analysis

Global Needle-free Drug Delivery Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Inhaler technology
• Transdermal patch technology
• Novel needle-free technologies

Global Needle-free Drug Delivery Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Vaccine delivery
• Pain management
• Insulin delivery for diabetes
• Pediatric injections
• Others

Global Needle-free Drug Delivery Devices Market Size & CAGR (2025-2032)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• PenJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zealand Pharma (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCB S.A. (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verdict Media Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INJEX Pharma AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antares Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crossject SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MannKind Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mika Medical Co. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Halozyme, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akra Dermojet (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring B.V. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MIIST Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations